Fullcircle Wealth LLC Buys New Holdings in CME Group Inc. (NASDAQ:CME)

Fullcircle Wealth LLC acquired a new position in shares of CME Group Inc. (NASDAQ:CME) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,407 shares of the financial services provider’s stock, valued at approximately $321,000.

Several other hedge funds have also recently bought and sold shares of the stock. Norden Group LLC bought a new position in CME Group in the first quarter valued at about $274,000. Private Advisor Group LLC boosted its position in CME Group by 3.9% during the 1st quarter. Private Advisor Group LLC now owns 4,592 shares of the financial services provider’s stock worth $989,000 after acquiring an additional 172 shares during the last quarter. Prosperity Consulting Group LLC bought a new stake in shares of CME Group during the 1st quarter worth approximately $237,000. Mirae Asset Global Investments Co. Ltd. raised its stake in shares of CME Group by 33.4% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 105,960 shares of the financial services provider’s stock worth $22,812,000 after purchasing an additional 26,536 shares in the last quarter. Finally, Janney Montgomery Scott LLC raised its stake in CME Group by 32.0% in the 1st quarter. Janney Montgomery Scott LLC now owns 52,167 shares of the financial services provider’s stock valued at $11,231,000 after acquiring an additional 12,653 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Stock Down 0.8 %

NASDAQ:CME traded down $1.75 during trading hours on Friday, reaching $223.61. The company’s stock had a trading volume of 1,318,587 shares, compared to its average volume of 1,917,520. The company has a market capitalization of $80.52 billion, a P/E ratio of 23.51, a price-to-earnings-growth ratio of 5.72 and a beta of 0.55. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $230.36. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a 50 day moving average price of $220.69 and a two-hundred day moving average price of $209.46.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the business posted $2.25 earnings per share. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. Equities analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were paid a dividend of $1.15 per share. The ex-dividend date of this dividend was Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.06%. CME Group’s dividend payout ratio (DPR) is presently 48.37%.

Insiders Place Their Bets

In other CME Group news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares of the company’s stock, valued at $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. In related news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 15,221 shares of company stock valued at $3,351,895 in the last 90 days. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Bank of America upped their price objective on CME Group from $177.00 to $180.00 and gave the company an “underperform” rating in a report on Thursday, October 3rd. Morgan Stanley raised their price objective on CME Group from $210.00 to $233.00 and gave the company an “equal weight” rating in a research note on Thursday, October 17th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 target price on shares of CME Group in a research report on Thursday, October 24th. Redburn Atlantic downgraded CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective for the company. in a research report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research report on Thursday, August 15th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have assigned a buy rating to the company. According to MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $222.73.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.